» Articles » PMID: 32599099

Impact of Antibiotic Prescription on the Resistance of Klebsiella Pneumoniae at a Tertiary Hospital in China, 2012-2019

Overview
Date 2020 Jun 30
PMID 32599099
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The incidence of Klebsiella pneumoniae (KP) infections is worrisome. Previous studies have shown that increased antibiotic treatment might affect the resistance profile of this organism. The objective of this study was to describe the resistance profile of KP strains and to correlate it with antibiotics consumption.

Methods: A retrospective observational analysis was performed to examine exposure to antibiotics and resistant profile, comparing the results of different measuring outcomes of resistance (the incidence and the percentage of resistant KP) during January 2012 to June 2019 by using the autoregressive integrated moving average and transfer function model.

Results: During the study period, the use of some third-generation cephalosporins and carbapenems continued to increase and a total of 5,519 KP isolates were collected. There were positive relationships between amikacin-resistant KP, ciprofloxacin-resistant KP, and corresponding antibiotic use in the transfer function models; both for the incidence rate and the resistant rate (time lag = 0) (P < .05).

Conclusions: The present study confirms that the history of amikacin or ciprofloxacin use influences the susceptibility of these agents against KP with no delay. Similar results were obtained with different measuring outcomes of resistance.

Citing Articles

Resistance Pattern of in Aseer Region, Saudi Arabia: A Ten-Year Hospital-Based Study.

Alshehri S, Abdullah N, Algarni A, AlZomia A, Assiry M Medicina (Kaunas). 2024; 60(8).

PMID: 39202625 PMC: 11356269. DOI: 10.3390/medicina60081344.


Usefulness of dynamic regression time series models for studying the relationship between antimicrobial consumption and bacterial antimicrobial resistance in hospitals: a systematic review.

Laffont-Lozes P, Larcher R, Salipante F, Leguelinel-Blache G, Dunyach-Remy C, Lavigne J Antimicrob Resist Infect Control. 2023; 12(1):100.

PMID: 37697357 PMC: 10496333. DOI: 10.1186/s13756-023-01302-3.


Phytochemicals: A Promising Weapon in the Arsenal against Antibiotic-Resistant Bacteria.

Khameneh B, Eskin N, Iranshahy M, Bazzaz B Antibiotics (Basel). 2021; 10(9).

PMID: 34572626 PMC: 8472480. DOI: 10.3390/antibiotics10091044.


Prior Antibiotic Therapy and the Onset of Healthcare-Associated Infections Sustained by Multidrug-Resistant in Intensive Care Unit Patients: A Nested Case-Control Study.

Migliara G, Baccolini V, Isonne C, Cianfanelli S, Di Paolo C, Mele A Antibiotics (Basel). 2021; 10(3).

PMID: 33804087 PMC: 8000440. DOI: 10.3390/antibiotics10030302.